Yang Cheng, Ph.D., is a Professor and the Vice Dean of the Wuxi Medical School at Jiangnan University. He is recognized as a Jiangsu Province 333 High-level Talent, Jiangsu May 1st Innovation Expert, and a Jiangnan University Zhishan Young Scholar. Educational Background: 2014-2016: Postdoctoral Fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA 2010-2014: Ph.D. in Human Parasitology, Kangwon National University, South Korea 2004-2009: Bachelor’s degree in Clinical Medicine, Bengbu Medical College Work Experience: 2023-present: Professor, Wuxi Medical School, Jiangnan University 2023-present: Vice Dean, Wuxi Medical School, Jiangnan University 2016-2023: Associate Professor, Wuxi Medical School, Jiangnan University April 2019-October 2020: Deputy Director of the Science and Education Department and Office Deputy Director, Wuxi Municipal Health Commission (temporary position) Research: Professor Cheng’s research focuses on the mechanisms of Plasmodium invasion and immune evasion, malaria vaccine development, and malaria control strategies. He has led projects funded by the Jiangsu Province Natural Science Foundation (2023-2025), the National Natural Science Foundation of China (2018-2022), and other prominent funding bodies, including the Bill & Melinda Gates Foundation Grand Challenges project (2016-2018) and the Good Venture Foundation (2017-2019). He holds nine national invention patents and has received several awards, including the First Prize in Science and Technology from the China Commercial Federation and the Third Prize in Science and Technology from Jiangsu Higher Education Institutions. Teaching: Professor Cheng teaches the course "Human Parasitology," recognized as a provincial first-class course. He is the chief editor of one textbook, associate editor of another, and contributor to three additional textbooks. He has led key educational reform projects and received numerous teaching awards, including the Second Prize for National Teaching Achievement (Undergraduate) and the Special Prize for Jiangsu Provincial Teaching Achievement. Professional Affiliations and Editorial Work: Professor Cheng is a board member of the Jiangsu Youth Science and Technology Workers Association and a committee member of several academic societies, including the Jiangsu Medical Association’s Tropical Diseases and Parasitology Division and the Jiangsu Society of Microbiology and Immunology. He serves as a reviewer for journals such as Advanced Science, Emerging Microbes and Infections, and Infection and Immunity, and is on the youth editorial boards of the Chinese Journal of Parasitology and Parasitic Diseases and the Chinese Journal of Schistosomiasis Control. Recent Publications (Selected as Corresponding Author): [1] The Plasmodium vivax MSP1P-19 is involved in binding of reticulocytes through interactions with the membrane proteins band3 and CD71. Zuo S, Lu J, Sun Y, Song J, Han S, Feng X, Han ET,Cheng Y. J Biol Chem. 2024 May. [2] Plasmodium yoelii surface related-antigen (PySRA) modulates the host pro-inflammatory responses via binding to CD68 on macrophage membrane. Feng X, Yu JL, Sun YF, Du CY, Shen Y, Zhang L, Kong WZ, Han S,Cheng Y. Infect Immun. 2024 Apr. [3] Plasmodium vivax Protein PvTRAg23 Triggers Spleen Fibroblasts for Inflammatory Profile and Reduces Type I Collagen Secretion via NF-κBp65 Pathway. Zhang H, Shen F, Yu J, Ge J, Sun Y, Fu H,Cheng Y. Front Immunol. 2022 Jun 13. [4] Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) interacts with the band 3 receptor to promote erythrocyte invasion by malaria parasites. Lu J, Chu R, Yin Y, Yu H, Xu Q, Yang B, Sun Y, Song J, Wang Q, Xu J, Lu F,Cheng Y. J Biol Chem. 2022 Apr. [5] Genetic diversity and immunogenicity of the merozoite surface protein 1 C-terminal 19-kDa fragment of Plasmodium ovale imported from Africa into China. Xu Q, Liu S, Kassegne K, Yang B, Lu J, Sun Y, Zhong W, Zhang M, Liu Y, Zhu G, Cao J,Cheng Y. Parasit Vectors. 2021 Nov 24. [6] A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites In Vitro. Shen FH, Ong JJY, Sun YF, Lei Y, Chu RL, Kassegne K, Fu HT, Jin C, Han ET, Russell B, Han JH,Cheng Y. Infect Immun. 2021 Jan 19. [7] Fangcang shelter hospitals are a One Health approach for responding to the COVID-19 outbreak in Wuhan, China. Wang KW, Gao J, Song XX, Huang J, Wang H, Wu XL, Yuan QF, Li XS, Cheng F,Cheng Y. One Health. 2020 Aug 29. [8] STING or Sting: cGAS-STING-Mediated Immune Response to Protozoan Parasites. Sun Y,Cheng Y. Trends Parasitol. 2020 Sep. [9] Low genetic diversity and strong immunogenicity within the apical membrane antigen-1 of plasmodium ovale spp. imported from africa to china. Lei Y, Shen F, Zhu H, Zhu L, Chu R, Tang J, Yao W, Zhu G, Zhang D, Cao J,Cheng Y. Acta Trop. 2020 Oct. [10] Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study. Wang KW, Gao J, Wang H, Wu XL, Yuan QF, Guo FY, Zhang ZJ,Cheng Y. Travel Med Infect Dis. 2020 May-Jun. |
